Opioid

• The Void in Clinician Counseling of Cannabis Use (24 Sep 2024)
  
• Cannabis as a Gateway Drug for Opioid Use Disorder (16 Sep 2024)
  
• Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective (16 Sep 2024)
  
• Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database (16 Sep 2024)
  
• Patients’ perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients (02 Sep 2024)
  
• Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery (02 Sep 2024)
  
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality (02 Sep 2024)
  
• An answered call for aid? Cannabinoid clinical framework for the opioid epidemic (02 Sep 2024)
  
• Influence of Cannabinoid Treatment on Trajectories of Patient-Related Outcomes in Chronic Pain: Pain Intensity, Emotional Distress, Tolerability and Physical Disability (29 Aug 2024)
  
• Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment (20 Aug 2024)
  
• Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells (27 Nov 2022)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
  
• A critical review of cannabis in medicine and dentistry: A look back and the path forward (31 Jul 2022)
  
• Some cannabis products associated with short-term chronic pain improvements, but side effects a concern (18 Jul 2022)
  
• CBD reduces craving and anxiety in people with heroin use disorder (18 Jul 2022)
  
• CBD and THC are Safe Supplements to Opioid Treatment (18 Jul 2022)
  
• Animal study shows safety of using CBD and THC with opioids (18 Jul 2022)